Ill. Admin. Code tit. 77, § 661.40 - Genetic and Metabolic Diseases Advisory Board
a)
The Director shall create the
Genetic and Metabolic Diseases Advisory Committee to advise the Department
regarding issues relevant to newborn screenings of metabolic diseases
and other newborn non-metabolic conditions (Section 5(a) of the Genetic and
Metabolic Diseases Advisory Committee Act).
b) The Advisory Committee shall:
1)
Advise the Department regarding
issues relevant to its Genetic Program;
2)
Advise the Department regarding
optimal laboratory methodologies for screening of the targeted
conditions;
3)
Recommend to the Department consultants who are qualified to diagnose a
condition detected by screening, provide management of care, and genetic
counseling for the family;
4)
Monitor the incidence of each
condition for which newborn screening is done, evaluate the effects of
treatment and genetic counseling, and provide advice on disorders to be
included in newborn screening panel;
5)
Advise the Department on
educational programs for professionals and the general public;
and
6)
Advise the
Department on new developments and areas of interest in relation to
the Department's Genetics Program (Section 5(b) of
the Genetic and Metabolic Diseases Advisory Committee Act).
c) The Advisory Committee
shall consist of 20 members appointed by the Director. Membership shall
include physicians, geneticists, nurses, nutritionists, and other allied health
professionals, as well as patients and parents. Ex-officio members may be
appointed, but shall not have voting privileges. (Section 5(c) of the
Genetic and Metabolic Diseases Advisory Committee Act).
d) The addition of specific disorders to this
Part shall be reviewed by the Advisory Committee. The Department will consider
the recommendations of the Advisory Committee in determining whether to include
an additional disorder in the screening panel. Implementation of the
Department's determination is subject to that determination's adoption by
rule.
Notes
State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.
No prior version found.